Ken Griffin's position in Adaptive Biotechnologies is currently worth $7.41 Thousand. That's 0.00% of their equity portfolio (4886th largest holding). The first Adaptive Biotechnologies trade was made in Q2 2019. Since then Ken Griffin bought shares eight more times and sold shares on nine occasions. The investor's estimated purchase price is $74.1 Thousand, resulting in a loss of 90%.